Search For "usf"
Indoco's Goa plant gets warning letter from USFDA
Updated : 6 years, 10 months ago IST
Mumbai (Maharashtra) [India], July 15 (ANI): Pharma company Indoco Remedies said on Monday it has received a warning letter from the United States Food and Drug Administration (USFDA) for its oral dosages plant in Goa as a result of the inspection carried out in January.
Read More
USFDA finds zero 483 observations and grants NAI to Centaur Pharmaceutical
Updated : 6 years, 11 months ago IST
Pune (Maharashtra) [India] June 11 (ANI/BusinessWire India): Mumbai based Centaur Pharmaceuticals' finished dosage facility in Pune was audited by the USFDA in May 2019 and the audit was concluded with NIL 483 observations.
Read More
North Korean media criticises US military over THAAD training
Updated : 7 years ago IST
Seoul [South Korea], May 10 (ANI): The North Korean media on Friday lashed out at the United States Forces Korea (USFK), a sub-unified command of US Indo-Pacific Command, over its recent military training involving an advanced missile defence system.
Read More
Jubilant Life Sciences to address USFDA concerns after warning
Updated : 7 years, 2 months ago IST
Noida (Uttar Pradesh) [India], Mar 8 (ANI): Jubilant Life Sciences said on Friday that the US Food and Drug Administration (USFDA) has issued a warning letter after conducting an inspection at its manufacturing facility in Roorkee, Uttarakhand.
Read More
Gujarat based Espee Group gets USFDA approval for their manufacturing plan
Updated : 7 years, 2 months ago IST
New Delhi [India], Feb 26 (ANI): Aavis Pharmaceuticals, part of Espee Group, located in Hoschton, GA, completed an inspection by the US Food and Drug Administration at the company’s primary manufacturing facility with Zero 483 observations. With successful inspection of its formulat
Read More
Twin USFDA approvals for Morepen Labs' bulk drugs (API) facilities
Updated : 7 years, 9 months ago IST
New Delhi [India], July 30 (NewsVoir): Morepen Laboratories Ltd. has received US FDA (United States Food and Drug Administration) approvals for both its bulk drugs manufacturing facilities situated in Himachal Pradesh.
Read More
S Korea dismisses US' renewed demand of cost sharing on strategic assets
Updated : 7 years, 11 months ago IST
Seoul [South Korea], June 28 (ANI): South Korea has declined a renewed demand from the United States to share the costs of deploying U.S. troops (its strategic assets) in and around the Korean Peninsula.
Read More
US targets Taliban leaders in Helmand
Updated : 7 years, 12 months ago IST
Helmand [Afghanistan], May 25 (ANI): A ground-based rocket artillery was carried out against Taliban leaders in Musa Qala district in Helmand, Task Force-Southwest, under US Forces-Afghanistan (USFOR-A) authorities confirmed on Thursday.
Read More
S Korean President Dismisses US Troop withdrawal
Updated : 8 years ago IST
Seoul [South Korea], May 2 (ANI): South Korean President Moon Jae In has dismissed the idea of withdrawing US troops from the country if a peace treaty were to be signed to formally end the Korean War.
Read More
Morepen Labs reports 107 pct increase in net profit for Q3 FY 2017-18
Updated : 8 years, 4 months ago IST
New Delhi [India], Jan 22 (ANI-NewsVoir): Morepen Laboratories Ltd has reported yet another growth-filled quarter by registering 107 per cent rise in its net profit in Q3 of FY 2017-18 at Rs. 9.67 crore, despite a marginal rise in its net sales revenue at Rs. 139.87 crore, compared to the co
Read More
India fast emerging as inventors' hub for drugs patent
Updated : 8 years, 5 months ago IST
Chandigarh [India], Dec 24 (ANI): India is fast emerging as an inventors' hub for patents for an assortment of drugs worldwide. Around 15 per cent of the total 1.3 lakh patents filed in India from 2013 to 2015 have been contributed by the indigenous pharmaceutical industry. India is ranked
Read More
Morepen Gets US FDA clearance for its Bulk Drug Montelukast Sodium
Updated : 8 years, 5 months ago IST
New Delhi [India], Dec 20 (ANI-NewsVoir): The United States Food and Drug Administration (USFDA) has cleared Montelukast Sodium, a bulk drug / API manufactured by Morepen Laboratories Ltd., for sale in the US market. This gives Morepen an entry into the Rs. 2000 crore (Approx. $ 300 million)
Read More